{"id":40146,"date":"2011-10-10T14:41:33","date_gmt":"2011-10-10T19:41:33","guid":{"rendered":""},"modified":"2026-02-18T16:26:56","modified_gmt":"2026-02-18T21:26:56","slug":"colorectal-cancer-screening-sigmoidoscopy-supplement1","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-cancer-screening-sigmoidoscopy-supplement1\/","title":{"rendered":"D\u00e9pistage du cancer colorectal : 1<sup>er<\/sup> suppl\u00e9ment au 2<sup>e<\/sup> m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2011)"},"content":{"rendered":"<p>Ce document fournit les r\u00e9sultats des constatations de suivi de l\u2019essai SCORE et constitue une annexe au deuxi\u00e8me m\u00e9moire de surveillance sur la sigmo\u00efdoscopie flexible (lien). Ce document fournit des renseignements qui peuvent \u00eatre utilis\u00e9s par les organismes provinciaux de lutte contre le cancer pour mettre les r\u00e9sultats de l\u2019essai en contexte.<\/p>\n<p>Le <a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&amp;p=40137\" target=\"_blank\" rel=\"noopener\">premier m\u00e9moire de surveillance<\/a>\u00a0s\u2019est pench\u00e9 sur les r\u00e9sultats relatifs aux d\u00e9c\u00e8s dus au cancer colorectal provenant de l\u2019essai NORCCAP, publi\u00e9 en juin\u00a02009. Le <a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-cancer-screening-sigmoidoscopy-brief2\/\" target=\"_blank\" rel=\"noopener\">deuxi\u00e8me m\u00e9moire de surveillance<\/a> s\u2019est pench\u00e9 sur les r\u00e9sultats relatifs aux d\u00e9c\u00e8s dus au cancer colorectal provenant de l\u2019essai UK\u00a0FS, publi\u00e9 en avril\u00a02010.<\/p>\n<p>De nouvelles donn\u00e9es probantes provenant de l\u2019essai SCORE appuient le d\u00e9pistage unique par sigmo\u00efdoscopie flexible pour le cancer colorectal chez les personnes \u00e0 risque moyen \u00e2g\u00e9es de 55 \u00e0 64\u00a0ans. L\u2019\u00e9tude a indiqu\u00e9 la fr\u00e9quence du cancer colorectal et le nombre d\u00e9c\u00e8s dus \u00e0 ce cancer en fonction de l\u2019intention de traiter et des analyses selon le protocole.<\/p>\n<p>L\u2019analyse selon l\u2019intention de traiter a r\u00e9v\u00e9l\u00e9 une diminution de 18\u00a0% de la fr\u00e9quence du cancer colorectal et une diminution de 22\u00a0% du nombre de d\u00e9c\u00e8s dus \u00e0 ce cancer. La diminution des d\u00e9c\u00e8s dus au cancer colorectal n\u2019\u00e9tait pas statistiquement significative.<\/p>\n<p>Toutefois, l\u2019analyse selon le protocole a fait \u00e9tat d\u2019une diminution significative de la fr\u00e9quence du cancer colorectal et du nombre de d\u00e9c\u00e8s dus \u00e0 ce cancer, soit de 31\u00a0% et de 38\u00a0%, respectivement.<\/p>\n<p>Ces r\u00e9sultats, combin\u00e9s \u00e0 ceux de l\u2019essai UK\u00a0FS, soulignent la n\u00e9cessit\u00e9 de se pencher sur le r\u00f4le que pourrait jouer la sigmo\u00efdoscopie flexible dans les programmes organis\u00e9s de d\u00e9pistage du cancer colorectal au Canada.<\/p>\n<p><strong>Document \u00e0 t\u00e9l\u00e9charger <\/strong>(en anglais seulement)<\/p>\n<div class=\"documents col-md-12\"><div>\n                                <i class=\"fas fa-file-pdf document-icon\"><\/i>\n                                <div class=\"document-details\">\n                                    <a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2019\/01\/Flex-Sigmoid-1Supplement-EN.pdf\" target=\"_blank\">Flexible sigmoidoscopy: Supplement to second watching brief<\/a><p class=\"file-information\">Taille du fichier 386 KB<\/p>         <\/div>\n                            <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ce document fournit les r\u00e9sultats des constatations de suivi de l\u2019essai SCORE et constitue une annexe au deuxi\u00e8me m\u00e9moire de surveillance sur la sigmo\u00efdoscopie flexible (lien). Ce document fournit des renseignements qui peuvent \u00eatre utilis\u00e9s par les organismes provinciaux de lutte contre le cancer pour mettre les r\u00e9sultats de l\u2019essai en contexte. Le premier m\u00e9moire [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":0,"menu_order":0,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[1647],"cancer-system-measurement":[],"dbt-cancer-site":[475],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-40146","topics","type-topics","status-publish","hentry","cancer-continuum-screening-fr","dbt-cancer-site-dbv-colorectal-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00e9pistage du cancer colorectal : 1er suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2011) - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Ce document fournit les r\u00e9sultats des constatations de suivi de l\u2019essai SCORE et constitue une annexe au deuxi\u00e8me m\u00e9moire de surveillance sur la sigmo\u00efdoscopie flexible (lien). Ce document fournit des renseignements qui peuvent \u00eatre utilis\u00e9s par les organismes provinciaux de lutte contre le cancer pour mettre les r\u00e9sultats de l\u2019essai en contexte. Le premier m\u00e9moire [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&amp;p=40146\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-18T21:26:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40146\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40146\",\"name\":\"D\u00e9pistage du cancer colorectal : 1er suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2011) - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2011-10-10T19:41:33+00:00\",\"dateModified\":\"2026-02-18T21:26:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40146#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40146\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40146#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"D\u00e9pistage du cancer colorectal : 1er suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2011)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146","og_locale":"fr_FR","og_type":"article","og_title":"D\u00e9pistage du cancer colorectal : 1er suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2011) - Canadian Partnership Against Cancer","og_description":"Ce document fournit les r\u00e9sultats des constatations de suivi de l\u2019essai SCORE et constitue une annexe au deuxi\u00e8me m\u00e9moire de surveillance sur la sigmo\u00efdoscopie flexible (lien). Ce document fournit des renseignements qui peuvent \u00eatre utilis\u00e9s par les organismes provinciaux de lutte contre le cancer pour mettre les r\u00e9sultats de l\u2019essai en contexte. Le premier m\u00e9moire [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2026-02-18T21:26:56+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146","name":"D\u00e9pistage du cancer colorectal : 1er suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2011) - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2011-10-10T19:41:33+00:00","dateModified":"2026-02-18T21:26:56+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40146#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"D\u00e9pistage du cancer colorectal : 1er suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2011)"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/40146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=40146"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=40146"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=40146"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=40146"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=40146"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=40146"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=40146"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=40146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}